Skip to main content
logo
Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.470
-0.020 (-1.34%)
Oct 2, 2026, 4:00 PM EDT - Market closed

Lisata Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.10.171---
Revenue Growth
-90.65%-83.00%----
Gross Profit
0.10.171---
Operating Income
-16.43-18.21-22.41-25.71-27.21-29.05
Net Income
-14.62-16.59-19.99-20.84-54.23-27.47
Earnings Per Share
-1.64-1.91-2.40-2.58-10.47-7.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10.4415.9631.2550.5469.2394.97
Total Debt
--0.140.310.490.71
Net Cash (Debt)
10.4415.9631.1150.2368.7494.26
Net Cash Growth
-52.36%-48.71%-38.07%-26.93%-27.07%177.64%
Net Cash Per Share
1.171.843.736.2213.2725.56

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.32-15.95-19.36-20.03-21.17-22.25
Capital Expenditures
--0.03---0.29-0.06
Free Cash Flow
-12.32-15.98-19.36-20.03-21.46-22.31
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-16426.00%-10711.18%-2240.90%---
Pretax Margin
-15008.00%-10322.35%-2078.30%---
Profit Margin
-14621.00%-9756.47%-1998.50%---
FCF Margin
-12323.00%-9398.24%-1935.60%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
132.4696.5125.02---